285 Phase I clinical trial evaluating the safety of ADP-A2M10 in patients with MAGE-A10+ head and neck, melanoma, or urothelial tumors

Lignende værker

• 285 Phase I clinical trial evaluating the safety of ADP-A2M10 in patients with MAGE-A10+ head and neck, melanoma, or urothelial tumors
  af: Marcus Butler, et al.
  Udgivet: (2020-11-01)
• Suppression of MAGE-A10 alters the metastatic phenotype of tongue squamous cell carcinoma cells
  af: Bruna dos Santos Mendonça, et al.
  Udgivet: (2017-07-01)
• Comprehensive analysis of MAGE-A10 in pan-cancer and its validation in gastric cancer
  af: Yichen Yin, et al.
  Udgivet: (2025-09-01)
• A Novel Recombinant MAGE-B10-HSP110 Fusion Protein Enhances Innate and Adaptive Immune Responses in Mice: A Potential Vaccine Candidate for Canine Mammary Tumors
  af: Anucha Muenthaisong, et al.
  Udgivet: (2026-04-01)
• Novel Universal Primers to Identify the Expression of MAGE A1-A10 in the Core Biopsy of Lung Cancer
  af: Gondo Mastutik, et al.
  Udgivet: (2021-01-01)